Skip to content
Presenilin 1 Modulates Acetylcholinesterase Trafficking and Maturation.
61825
Cortés-Gómez, M.Á., Barberá, V.M., Alom, J., Sáez-Valero, J., García-Ayllón, M.-S.
61825
Int J Mol Sci.
61825
2023
61825
24(2): art. 1437
61825
https://doi.org/10.3390/ijms24021437
Proceedings of workshop: «Neuroglycoproteins in health and disease», INNOGLY cost action
62509
Llop, E., Ardá, A., Zacco, E., O’Flaherty, R., García-Ayllón, M.-S., Aureli, M., Frenkel-Pinter, M., Reis, C.A., Greiner-Tollersrud, O.K., Cuchillo-Ibáñez, I.
62509
Glycoconj Journal.
62509
2022
62509
39(5): 579-586
62509
https://doi.org/10.1007/s10719-022-10078-4
Serum angiotensin-converting enzyme 2 as a potential biomarker for SARS-CoV-2 infection and vaccine efficacy.
54340
Lennol, M.P., García-Ayllón, M.-S., Esteban, M., García-Arriaza, J., Sáez-Valero, J.
54340
Frontiers in Immunology
54340
2022
54340
13: art 1001951
54340
https://doi.org/10.3389/fimmu.2022.1001951
Relation between Alpha-Synuclein and Core CSF Biomarkers of Alzheimer’s Disease
33888
Monge-García V, García-Ayllón MS, Sáez-Valero J, Sánchez-Payá J, Navarrete-Rueda F, Manzanares-Robles J, Gasparini-Berenguer R, Romero-Lorenzo R, Cortés-Gómez MA, Monge-Argilés JA
33888
Medicina (Kaunas)
33888
2021
33888
57(9):954
33888
https://doi.org/10.3390/medicina57090954
Plasma ACE2 species are differentially altered in COVID-19 patients
33876
García-Ayllón MS, Moreno-Pérez O, García-Arriaza J, Ramos-Rincón JM, Cortés-Gómez MÁ, Brinkmalm G, Andrés M, León-Ramírez JM, Boix V, Gil J, Zetterberg H, Esteban M, Merino E, Sáez-Valero J
33876
FASEB J
33876
2021
33876
35(8):e21745
33876
https://doi.org/10.1096/fj.202100051R
Tau phosphorylation by glycogen synthase kinase 3 beta modulates enzyme acetylcholinesterase expression
33921
Cortés-Gómez MÁ, Llorens-Álvarez E, Alom J, Del Ser T, Avila J, Sáez-Valero J, García-Ayllón MS
33921
J Neurochem
33921
2021
33921
157(6):2091
33921
https://doi.org/10.1111/jnc.15189
a-Secretase nonsense mutation (ADAM10 Tyr167*) in familial Alzheimer’s disease
33984
Agüero P, Sainz MJ, García-Ayllón MS, Sáez-Valero J, Téllez R, Guerrero-López R, Pérez-Pérez J, Jiménez-Escrig A, Gómez-Tortosa E
33984
Alzheimers Res Ther
33984
2020
33984
12(1):139
33984
https://doi.org/10.1186/s13195-020-00708-0
Pre-analytical stability of novel cerebrospinal fluid biomarkers
34377
Willemse EAJ, Vermeiren Y, Garcia-Ayllon MS, Bridel C, De Deyn PP, Engelborghs S, van der Flier WM, Jansen EEW, Lopez-Font IB, Mendes V, Manadas B, de Roeck N, Saez-Valero J, Struys EA, Vanmechelen E, Andreasson U, Teunissen CE
34377
Clinica Chimica Acta
34377
2019
34377
497:204
34377
https://doi.org/10.1016/j.cca.2019.07.024
Measurement of CSF alpha-synuclein improves early differential diagnosis of mild cognitive impairment due to Alzheimer’s disease
34329
García-Ayllón MS, Monge-Argilés JA, Monge-García V, Navarrete F, Cortés-Gómez MA, Sánchez-Payá J, Manzanares J, Gasparini-Berenguer R, Leiva-Santana C, Sáez-Valero J
34329
Journal of Neurochemistry
34329
2019
34329
150(2):218
34329
https://doi.org/10.1111/jnc.14719
Inhibition of gamma-Secretase Leads to an Increase in Presenilin-1
34617
Sogorb-Esteve A, Garcia-Ayllon MS, Llansola M, Felipo V, Blennow K, Saez-Valero J
34617
Mol Neurobiol
34617
2018
34617
55(6):5047
34617
https://doi.org/10.1007/s12035-017-0705-1
Ver otros años